BioGaia Forecast, price target & analysts
BioGaia Target price 2026 - Analyst rating & recommendation
BioGaia Classifications & Recommendation
BioGaia Price Target
| Target Price | €14.45 |
| Price | €9.74 |
| Potential |
48.43%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target BioGaia 2027 .
The average BioGaia target price is €14.45.
This is
48.43%
register free of charge
€15.34
57.57%
register free of charge
€12.52
28.60%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend BioGaia to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioGaia stock has an average upside potential 2027 of
48.43%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 136.18 | 148.65 |
| 8.11% | 9.16% | |
| EBITDA Margin | 29.78% | 31.34% |
| 1.78% | 5.22% | |
| Net Margin | 21.63% | 23.58% |
| 12.41% | 9.00% |
3 Analysts have issued a sales forecast BioGaia 2026 . The average BioGaia sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an BioGaia EBITDA forecast 2026. The average BioGaia EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 BioGaia Analysts have issued a net profit forecast 2026. The average BioGaia net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.29 | 0.35 |
| 6.45% | 20.69% | |
| P/E | 28.09 | |
| EV/Sales | 6.37 |
3 Analysts have issued a BioGaia forecast for earnings per share. The average BioGaia EPS is
This results in the following potential growth metrics and future valuations:
Current BioGaia Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 06 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 05 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Feb 16 2026 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Feb 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 06 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 05 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Feb 16 2026 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Feb 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
